p38-MAPK can be activated by interferon and lipopolysaccharide to upregulate the expression of the depression-related gene IDO [97,98], and it can also exacerbate esophageal cancer-associated depression by directly enhancing the expression of the IDO gene [99]. Here, IDO1 is linked to depressive symptom measurement.